PATENT CLAIM ANALYSIS

Application Number: 15562825
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2019-04
Patent Classification: ["544", "183000"]

Abstract:
The present invention relates to a tyrosine kinase inhibitor and a pharmaceutical composition comprising same. The tyrosine kinase inhibitor of the present invention has the structures as shown in the following formula (I) or (II):

Claim (Index 25):
A compound or an enantiomer, a diastereomer, a geometric isomer, a solvate or a pharmaceutically acceptable salt thereof according to  claim 18 , wherein\n R 1  is R 2  is selected from H, CN, CF 3 ,

Metadata:
- Claim Count in Document: 56.0
- Percentile: 94.0
- Lexical Diversity: 1.36667
- Patent Class: 544.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15812142', '15750704', '16470111', '15314599', '16326976']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8165528224171263
- 35 USC 102 Novelty (BERT): 0.5345136733147839
- Combined Prediction Score: 0.7883489075068921
- Mean Citation Score: 357.22619
- Max Citation Score: 380.52487
- Similarity Product: 306.16048965263667

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test